Today, Delivra™ is a thriving company, with two very active segments.

The second is a leading and dynamic R&D program, focussed on continued expansion of the already robust capabilities of the Company’s patent-pending transdermal delivery system, for the purpose of developing new LivReliefTM products and licensing the delivery technology to pharmaceutical companies for use with a range of third-party natural and pharmaceutical molecules.